Repligen reported $64.54M in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agilent A:US USD 569M 66M
Align Technology ALGN:US USD 147.12M 71.35M
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Bruker BRKR:US USD 153.9M 44.8M
Catalent CTLT:US USD 161M 200M
Charles River Laboratories CRL:US USD 225.58M 38.25M
Danaher DHR:US USD 2.86B 306M
Dentsply International XRAY:US USD 148M 61M
Exact Sciences EXAS:US USD -83543000 17.59M
Fluidigm FLDM:US USD -25325000 9.16M
Henry Schein HSIC:US USD 273M 3M
Illumina ILMN:US USD 349M 225M
IQVIA Holdings Inc IQV:US USD 736M 9M
Mettler Toledo International MTD:US USD 320.79M 21.25M
Myriad Genetics MYGN:US USD -31900000 27.1M
Orasure Technologies OSUR:US USD 11.36M 18.33M
Patterson Companies PDCO:US USD 81.01M 25.98M
Peregrine Pharmaceuticals PPHM:US USD -865000 5.2M
Pfizer PFE:US USD 10.52B 2.78B
Repligen RGEN:US USD 64.54M 6.54M
Thermo Fisher Scientific TMO:US USD 2.58B 280M
Waters WAT:US USD 224.22M 10.15M
West Pharmaceutical Services WST:US USD 213.8M 41.8M